nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—ADRA1B—vas deferens—urinary bladder cancer	0.18	0.445	CbGeAlD
Apomorphine—HTR2A—urine—urinary bladder cancer	0.0163	0.0402	CbGeAlD
Apomorphine—ADRA1D—prostate gland—urinary bladder cancer	0.0157	0.0388	CbGeAlD
Apomorphine—Injection site reaction—Mitomycin—urinary bladder cancer	0.0155	0.0261	CcSEcCtD
Apomorphine—Pneumonia—Valrubicin—urinary bladder cancer	0.0128	0.0215	CcSEcCtD
Apomorphine—Cardiac failure congestive—Mitomycin—urinary bladder cancer	0.0125	0.021	CcSEcCtD
Apomorphine—CALY—lymph node—urinary bladder cancer	0.0124	0.0306	CbGeAlD
Apomorphine—Urinary tract infection—Valrubicin—urinary bladder cancer	0.0123	0.0208	CcSEcCtD
Apomorphine—ADRA1D—epithelium—urinary bladder cancer	0.0116	0.0285	CbGeAlD
Apomorphine—ADRA1B—renal system—urinary bladder cancer	0.011	0.0271	CbGeAlD
Apomorphine—DRD5—female reproductive system—urinary bladder cancer	0.0107	0.0264	CbGeAlD
Apomorphine—ADRA1D—urethra—urinary bladder cancer	0.0105	0.026	CbGeAlD
Apomorphine—Back pain—Valrubicin—urinary bladder cancer	0.0096	0.0161	CcSEcCtD
Apomorphine—Drowsiness—Mitomycin—urinary bladder cancer	0.00875	0.0147	CcSEcCtD
Apomorphine—ADRA2C—prostate gland—urinary bladder cancer	0.00862	0.0213	CbGeAlD
Apomorphine—ADRA1D—female reproductive system—urinary bladder cancer	0.0086	0.0212	CbGeAlD
Apomorphine—Chest pain—Valrubicin—urinary bladder cancer	0.00845	0.0142	CcSEcCtD
Apomorphine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00775	0.0191	CbGeAlD
Apomorphine—Rhinorrhoea—Cisplatin—urinary bladder cancer	0.00761	0.0128	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00738	0.0124	CcSEcCtD
Apomorphine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00729	0.018	CbGeAlD
Apomorphine—ADRA2A—prostate gland—urinary bladder cancer	0.00688	0.017	CbGeAlD
Apomorphine—HTR1A—renal system—urinary bladder cancer	0.00669	0.0165	CbGeAlD
Apomorphine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00667	0.0112	CcSEcCtD
Apomorphine—HTR1B—female reproductive system—urinary bladder cancer	0.00664	0.0164	CbGeAlD
Apomorphine—Injection site reaction—Gemcitabine—urinary bladder cancer	0.00657	0.0111	CcSEcCtD
Apomorphine—HTR1D—female reproductive system—urinary bladder cancer	0.00643	0.0158	CbGeAlD
Apomorphine—HTR2C—female reproductive system—urinary bladder cancer	0.00636	0.0157	CbGeAlD
Apomorphine—Syncope—Mitomycin—urinary bladder cancer	0.00613	0.0103	CcSEcCtD
Apomorphine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00601	0.0101	CcSEcCtD
Apomorphine—HTR2B—female reproductive system—urinary bladder cancer	0.00598	0.0147	CbGeAlD
Apomorphine—ADRA2C—renal system—urinary bladder cancer	0.00587	0.0145	CbGeAlD
Apomorphine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00582	0.0143	CbGeAlD
Apomorphine—Asthenia—Valrubicin—urinary bladder cancer	0.00581	0.00977	CcSEcCtD
Apomorphine—ADRA2C—urethra—urinary bladder cancer	0.00577	0.0142	CbGeAlD
Apomorphine—Pruritus—Valrubicin—urinary bladder cancer	0.00573	0.00964	CcSEcCtD
Apomorphine—Confusional state—Mitomycin—urinary bladder cancer	0.00562	0.00946	CcSEcCtD
Apomorphine—Oedema—Mitomycin—urinary bladder cancer	0.00558	0.00938	CcSEcCtD
Apomorphine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00554	0.00932	CcSEcCtD
Apomorphine—Shock—Mitomycin—urinary bladder cancer	0.00549	0.00923	CcSEcCtD
Apomorphine—HTR2B—vagina—urinary bladder cancer	0.00541	0.0133	CbGeAlD
Apomorphine—Dizziness—Valrubicin—urinary bladder cancer	0.00535	0.00901	CcSEcCtD
Apomorphine—Swelling—Fluorouracil—urinary bladder cancer	0.00535	0.009	CcSEcCtD
Apomorphine—Dehydration—Thiotepa—urinary bladder cancer	0.00531	0.00893	CcSEcCtD
Apomorphine—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.00529	0.0089	CcSEcCtD
Apomorphine—Vomiting—Valrubicin—urinary bladder cancer	0.00515	0.00866	CcSEcCtD
Apomorphine—Headache—Valrubicin—urinary bladder cancer	0.00507	0.00853	CcSEcCtD
Apomorphine—Dyspnoea—Mitomycin—urinary bladder cancer	0.00497	0.00836	CcSEcCtD
Apomorphine—Somnolence—Mitomycin—urinary bladder cancer	0.00496	0.00834	CcSEcCtD
Apomorphine—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00493	0.0083	CcSEcCtD
Apomorphine—Nausea—Valrubicin—urinary bladder cancer	0.00481	0.00809	CcSEcCtD
Apomorphine—Fatigue—Mitomycin—urinary bladder cancer	0.00481	0.00809	CcSEcCtD
Apomorphine—Swelling—Etoposide—urinary bladder cancer	0.00465	0.00782	CcSEcCtD
Apomorphine—ADRA2A—urethra—urinary bladder cancer	0.0046	0.0114	CbGeAlD
Apomorphine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0046	0.00773	CcSEcCtD
Apomorphine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00452	0.0076	CcSEcCtD
Apomorphine—Pneumonia—Thiotepa—urinary bladder cancer	0.00442	0.00744	CcSEcCtD
Apomorphine—HTR2A—epithelium—urinary bladder cancer	0.0043	0.0106	CbGeAlD
Apomorphine—ADRA2C—vagina—urinary bladder cancer	0.00425	0.0105	CbGeAlD
Apomorphine—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.00422	0.0071	CcSEcCtD
Apomorphine—Dehydration—Cisplatin—urinary bladder cancer	0.00416	0.007	CcSEcCtD
Apomorphine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00414	0.0102	CbGeAlD
Apomorphine—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00409	0.00687	CcSEcCtD
Apomorphine—Asthenia—Mitomycin—urinary bladder cancer	0.004	0.00673	CcSEcCtD
Apomorphine—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.004	0.00673	CcSEcCtD
Apomorphine—HTR2A—renal system—urinary bladder cancer	0.00399	0.00983	CbGeAlD
Apomorphine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.00397	0.00668	CcSEcCtD
Apomorphine—Hallucination—Thiotepa—urinary bladder cancer	0.00393	0.00661	CcSEcCtD
Apomorphine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00382	0.00642	CcSEcCtD
Apomorphine—Sweating increased—Cisplatin—urinary bladder cancer	0.00377	0.00634	CcSEcCtD
Apomorphine—ADRA2A—female reproductive system—urinary bladder cancer	0.00375	0.00926	CbGeAlD
Apomorphine—Pneumonia—Gemcitabine—urinary bladder cancer	0.00372	0.00626	CcSEcCtD
Apomorphine—Dizziness—Mitomycin—urinary bladder cancer	0.00369	0.0062	CcSEcCtD
Apomorphine—Pneumonia—Fluorouracil—urinary bladder cancer	0.00366	0.00615	CcSEcCtD
Apomorphine—Vomiting—Mitomycin—urinary bladder cancer	0.00355	0.00597	CcSEcCtD
Apomorphine—Urinary tract infection—Fluorouracil—urinary bladder cancer	0.00354	0.00595	CcSEcCtD
Apomorphine—HTR2B—lymph node—urinary bladder cancer	0.0035	0.00862	CbGeAlD
Apomorphine—Headache—Mitomycin—urinary bladder cancer	0.00349	0.00588	CcSEcCtD
Apomorphine—Mental disorder—Thiotepa—urinary bladder cancer	0.00346	0.00582	CcSEcCtD
Apomorphine—Sweating increased—Etoposide—urinary bladder cancer	0.00345	0.00581	CcSEcCtD
Apomorphine—ADRA2A—vagina—urinary bladder cancer	0.0034	0.00837	CbGeAlD
Apomorphine—Dyskinesia—Epirubicin—urinary bladder cancer	0.00337	0.00567	CcSEcCtD
Apomorphine—Back pain—Thiotepa—urinary bladder cancer	0.00332	0.00559	CcSEcCtD
Apomorphine—Nausea—Mitomycin—urinary bladder cancer	0.00331	0.00557	CcSEcCtD
Apomorphine—HTR2A—female reproductive system—urinary bladder cancer	0.00319	0.00787	CbGeAlD
Apomorphine—Pneumonia—Etoposide—urinary bladder cancer	0.00318	0.00534	CcSEcCtD
Apomorphine—Injection site reaction—Epirubicin—urinary bladder cancer	0.00315	0.00529	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00312	0.00524	CcSEcCtD
Apomorphine—Ecchymosis—Methotrexate—urinary bladder cancer	0.00306	0.00514	CcSEcCtD
Apomorphine—Arthralgia—Thiotepa—urinary bladder cancer	0.00293	0.00492	CcSEcCtD
Apomorphine—Anxiety—Thiotepa—urinary bladder cancer	0.00292	0.0049	CcSEcCtD
Apomorphine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00291	0.0049	CcSEcCtD
Apomorphine—HTR2A—vagina—urinary bladder cancer	0.00289	0.00712	CbGeAlD
Apomorphine—Flushing—Cisplatin—urinary bladder cancer	0.00287	0.00483	CcSEcCtD
Apomorphine—Ecchymosis—Epirubicin—urinary bladder cancer	0.00286	0.00481	CcSEcCtD
Apomorphine—Confusional state—Thiotepa—urinary bladder cancer	0.00283	0.00476	CcSEcCtD
Apomorphine—Back pain—Gemcitabine—urinary bladder cancer	0.0028	0.0047	CcSEcCtD
Apomorphine—ADRA2C—lymph node—urinary bladder cancer	0.00275	0.00679	CbGeAlD
Apomorphine—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00265	0.00445	CcSEcCtD
Apomorphine—Flushing—Etoposide—urinary bladder cancer	0.00263	0.00443	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00256	0.0043	CcSEcCtD
Apomorphine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00253	0.00426	CcSEcCtD
Apomorphine—Somnolence—Thiotepa—urinary bladder cancer	0.00249	0.00419	CcSEcCtD
Apomorphine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00246	0.00414	CcSEcCtD
Apomorphine—Chest pain—Gemcitabine—urinary bladder cancer	0.00246	0.00414	CcSEcCtD
Apomorphine—Chest pain—Fluorouracil—urinary bladder cancer	0.00242	0.00407	CcSEcCtD
Apomorphine—Fatigue—Thiotepa—urinary bladder cancer	0.00242	0.00407	CcSEcCtD
Apomorphine—Constipation—Thiotepa—urinary bladder cancer	0.0024	0.00403	CcSEcCtD
Apomorphine—Back pain—Etoposide—urinary bladder cancer	0.00239	0.00402	CcSEcCtD
Apomorphine—Oedema—Gemcitabine—urinary bladder cancer	0.00236	0.00397	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00234	0.00394	CcSEcCtD
Apomorphine—Confusional state—Fluorouracil—urinary bladder cancer	0.00234	0.00393	CcSEcCtD
Apomorphine—Oedema—Fluorouracil—urinary bladder cancer	0.00232	0.0039	CcSEcCtD
Apomorphine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00231	0.00389	CcSEcCtD
Apomorphine—Pain in extremity—Epirubicin—urinary bladder cancer	0.0023	0.00387	CcSEcCtD
Apomorphine—Anxiety—Cisplatin—urinary bladder cancer	0.00229	0.00385	CcSEcCtD
Apomorphine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00228	0.00384	CcSEcCtD
Apomorphine—Hypotension—Gemcitabine—urinary bladder cancer	0.0022	0.00371	CcSEcCtD
Apomorphine—Oedema—Cisplatin—urinary bladder cancer	0.0022	0.0037	CcSEcCtD
Apomorphine—ADRA2A—lymph node—urinary bladder cancer	0.0022	0.00542	CbGeAlD
Apomorphine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00217	0.00365	CcSEcCtD
Apomorphine—Hypotension—Fluorouracil—urinary bladder cancer	0.00217	0.00365	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00215	0.00362	CcSEcCtD
Apomorphine—Dehydration—Epirubicin—urinary bladder cancer	0.00214	0.00359	CcSEcCtD
Apomorphine—Insomnia—Gemcitabine—urinary bladder cancer	0.00213	0.00359	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00213	0.00358	CcSEcCtD
Apomorphine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00213	0.00358	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00211	0.00356	CcSEcCtD
Apomorphine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.0021	0.00354	CcSEcCtD
Apomorphine—Chest pain—Etoposide—urinary bladder cancer	0.0021	0.00354	CcSEcCtD
Apomorphine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.0021	0.00353	CcSEcCtD
Apomorphine—Insomnia—Fluorouracil—urinary bladder cancer	0.0021	0.00353	CcSEcCtD
Apomorphine—Somnolence—Gemcitabine—urinary bladder cancer	0.0021	0.00353	CcSEcCtD
Apomorphine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00207	0.00348	CcSEcCtD
Apomorphine—Somnolence—Fluorouracil—urinary bladder cancer	0.00206	0.00347	CcSEcCtD
Apomorphine—Hypotension—Cisplatin—urinary bladder cancer	0.00206	0.00346	CcSEcCtD
Apomorphine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00205	0.00346	CcSEcCtD
Apomorphine—Fatigue—Gemcitabine—urinary bladder cancer	0.00203	0.00342	CcSEcCtD
Apomorphine—Confusional state—Etoposide—urinary bladder cancer	0.00203	0.00342	CcSEcCtD
Apomorphine—Constipation—Gemcitabine—urinary bladder cancer	0.00202	0.00339	CcSEcCtD
Apomorphine—Asthenia—Thiotepa—urinary bladder cancer	0.00201	0.00339	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.002	0.00337	CcSEcCtD
Apomorphine—Pruritus—Thiotepa—urinary bladder cancer	0.00198	0.00334	CcSEcCtD
Apomorphine—Dehydration—Doxorubicin—urinary bladder cancer	0.00198	0.00333	CcSEcCtD
Apomorphine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00196	0.0033	CcSEcCtD
Apomorphine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00195	0.00328	CcSEcCtD
Apomorphine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00194	0.00327	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00194	0.00327	CcSEcCtD
Apomorphine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00193	0.00325	CcSEcCtD
Apomorphine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00192	0.00323	CcSEcCtD
Apomorphine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00191	0.00322	CcSEcCtD
Apomorphine—Pneumonia—Methotrexate—urinary bladder cancer	0.0019	0.0032	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.0019	0.0032	CcSEcCtD
Apomorphine—Drowsiness—Methotrexate—urinary bladder cancer	0.00189	0.00318	CcSEcCtD
Apomorphine—Hypotension—Etoposide—urinary bladder cancer	0.00188	0.00317	CcSEcCtD
Apomorphine—Dizziness—Thiotepa—urinary bladder cancer	0.00185	0.00312	CcSEcCtD
Apomorphine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00181	0.00305	CcSEcCtD
Apomorphine—Dyspnoea—Etoposide—urinary bladder cancer	0.0018	0.00302	CcSEcCtD
Apomorphine—Somnolence—Etoposide—urinary bladder cancer	0.00179	0.00301	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00179	0.00301	CcSEcCtD
Apomorphine—Vomiting—Thiotepa—urinary bladder cancer	0.00178	0.003	CcSEcCtD
Apomorphine—Pneumonia—Epirubicin—urinary bladder cancer	0.00178	0.003	CcSEcCtD
Apomorphine—Drowsiness—Epirubicin—urinary bladder cancer	0.00177	0.00298	CcSEcCtD
Apomorphine—Headache—Thiotepa—urinary bladder cancer	0.00176	0.00296	CcSEcCtD
Apomorphine—Fatigue—Etoposide—urinary bladder cancer	0.00174	0.00292	CcSEcCtD
Apomorphine—Constipation—Etoposide—urinary bladder cancer	0.00172	0.0029	CcSEcCtD
Apomorphine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00172	0.0029	CcSEcCtD
Apomorphine—Asthenia—Gemcitabine—urinary bladder cancer	0.00169	0.00285	CcSEcCtD
Apomorphine—Pruritus—Gemcitabine—urinary bladder cancer	0.00167	0.00281	CcSEcCtD
Apomorphine—Nausea—Thiotepa—urinary bladder cancer	0.00167	0.0028	CcSEcCtD
Apomorphine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00166	0.00279	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—urinary bladder cancer	0.00165	0.00277	CcSEcCtD
Apomorphine—Pruritus—Fluorouracil—urinary bladder cancer	0.00164	0.00276	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00164	0.00276	CcSEcCtD
Apomorphine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00161	0.00272	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00159	0.00268	CcSEcCtD
Apomorphine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00159	0.00267	CcSEcCtD
Apomorphine—Asthenia—Cisplatin—urinary bladder cancer	0.00158	0.00265	CcSEcCtD
Apomorphine—Dizziness—Fluorouracil—urinary bladder cancer	0.00153	0.00258	CcSEcCtD
Apomorphine—Diarrhoea—Cisplatin—urinary bladder cancer	0.0015	0.00253	CcSEcCtD
Apomorphine—Vomiting—Gemcitabine—urinary bladder cancer	0.0015	0.00252	CcSEcCtD
Apomorphine—Mental disorder—Methotrexate—urinary bladder cancer	0.00149	0.0025	CcSEcCtD
Apomorphine—Headache—Gemcitabine—urinary bladder cancer	0.00148	0.00249	CcSEcCtD
Apomorphine—Flushing—Epirubicin—urinary bladder cancer	0.00148	0.00248	CcSEcCtD
Apomorphine—Vomiting—Fluorouracil—urinary bladder cancer	0.00148	0.00248	CcSEcCtD
Apomorphine—Headache—Fluorouracil—urinary bladder cancer	0.00145	0.00244	CcSEcCtD
Apomorphine—Asthenia—Etoposide—urinary bladder cancer	0.00145	0.00243	CcSEcCtD
Apomorphine—Back pain—Methotrexate—urinary bladder cancer	0.00143	0.00241	CcSEcCtD
Apomorphine—Pruritus—Etoposide—urinary bladder cancer	0.00143	0.0024	CcSEcCtD
Apomorphine—Nausea—Gemcitabine—urinary bladder cancer	0.0014	0.00236	CcSEcCtD
Apomorphine—Vomiting—Cisplatin—urinary bladder cancer	0.0014	0.00235	CcSEcCtD
Apomorphine—Mental disorder—Epirubicin—urinary bladder cancer	0.00139	0.00234	CcSEcCtD
Apomorphine—Diarrhoea—Etoposide—urinary bladder cancer	0.00138	0.00232	CcSEcCtD
Apomorphine—Nausea—Fluorouracil—urinary bladder cancer	0.00138	0.00232	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—urinary bladder cancer	0.00137	0.0023	CcSEcCtD
Apomorphine—Back pain—Epirubicin—urinary bladder cancer	0.00134	0.00225	CcSEcCtD
Apomorphine—Dizziness—Etoposide—urinary bladder cancer	0.00133	0.00224	CcSEcCtD
Apomorphine—Nausea—Cisplatin—urinary bladder cancer	0.00131	0.0022	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—urinary bladder cancer	0.00129	0.00217	CcSEcCtD
Apomorphine—Vomiting—Etoposide—urinary bladder cancer	0.00128	0.00215	CcSEcCtD
Apomorphine—Headache—Etoposide—urinary bladder cancer	0.00126	0.00212	CcSEcCtD
Apomorphine—Arthralgia—Methotrexate—urinary bladder cancer	0.00126	0.00212	CcSEcCtD
Apomorphine—Chest pain—Methotrexate—urinary bladder cancer	0.00126	0.00212	CcSEcCtD
Apomorphine—Syncope—Epirubicin—urinary bladder cancer	0.00124	0.00209	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—urinary bladder cancer	0.00124	0.00208	CcSEcCtD
Apomorphine—Confusional state—Methotrexate—urinary bladder cancer	0.00122	0.00205	CcSEcCtD
Apomorphine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00122	0.00205	CcSEcCtD
Apomorphine—Nausea—Etoposide—urinary bladder cancer	0.0012	0.00201	CcSEcCtD
Apomorphine—Arthralgia—Epirubicin—urinary bladder cancer	0.00118	0.00198	CcSEcCtD
Apomorphine—Chest pain—Epirubicin—urinary bladder cancer	0.00118	0.00198	CcSEcCtD
Apomorphine—Anxiety—Epirubicin—urinary bladder cancer	0.00117	0.00197	CcSEcCtD
Apomorphine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00117	0.00196	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—urinary bladder cancer	0.00115	0.00193	CcSEcCtD
Apomorphine—Confusional state—Epirubicin—urinary bladder cancer	0.00114	0.00192	CcSEcCtD
Apomorphine—Oedema—Epirubicin—urinary bladder cancer	0.00113	0.0019	CcSEcCtD
Apomorphine—Hypotension—Methotrexate—urinary bladder cancer	0.00113	0.0019	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00113	0.00189	CcSEcCtD
Apomorphine—Shock—Epirubicin—urinary bladder cancer	0.00111	0.00187	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0011	0.00185	CcSEcCtD
Apomorphine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00109	0.00184	CcSEcCtD
Apomorphine—Insomnia—Methotrexate—urinary bladder cancer	0.00109	0.00184	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—urinary bladder cancer	0.00109	0.00183	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—urinary bladder cancer	0.00109	0.00183	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—urinary bladder cancer	0.00109	0.00183	CcSEcCtD
Apomorphine—Dyspnoea—Methotrexate—urinary bladder cancer	0.00108	0.00181	CcSEcCtD
Apomorphine—Somnolence—Methotrexate—urinary bladder cancer	0.00107	0.0018	CcSEcCtD
Apomorphine—Hypotension—Epirubicin—urinary bladder cancer	0.00106	0.00178	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—urinary bladder cancer	0.00105	0.00177	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—urinary bladder cancer	0.00105	0.00176	CcSEcCtD
Apomorphine—Fatigue—Methotrexate—urinary bladder cancer	0.00104	0.00175	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00103	0.00173	CcSEcCtD
Apomorphine—Shock—Doxorubicin—urinary bladder cancer	0.00103	0.00173	CcSEcCtD
Apomorphine—Insomnia—Epirubicin—urinary bladder cancer	0.00102	0.00172	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00101	0.0017	CcSEcCtD
Apomorphine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00101	0.00169	CcSEcCtD
Apomorphine—Somnolence—Epirubicin—urinary bladder cancer	0.001	0.00169	CcSEcCtD
Apomorphine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000995	0.00167	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—urinary bladder cancer	0.000976	0.00164	CcSEcCtD
Apomorphine—Fatigue—Epirubicin—urinary bladder cancer	0.000974	0.00164	CcSEcCtD
Apomorphine—Constipation—Epirubicin—urinary bladder cancer	0.000966	0.00162	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000952	0.0016	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—urinary bladder cancer	0.000945	0.00159	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000932	0.00157	CcSEcCtD
Apomorphine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000931	0.00157	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—urinary bladder cancer	0.000929	0.00156	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—urinary bladder cancer	0.000901	0.00152	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—urinary bladder cancer	0.000894	0.0015	CcSEcCtD
Apomorphine—Asthenia—Methotrexate—urinary bladder cancer	0.000866	0.00146	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000861	0.00145	CcSEcCtD
Apomorphine—Pruritus—Methotrexate—urinary bladder cancer	0.000854	0.00144	CcSEcCtD
Apomorphine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000826	0.00139	CcSEcCtD
Apomorphine—Asthenia—Epirubicin—urinary bladder cancer	0.00081	0.00136	CcSEcCtD
Apomorphine—Pruritus—Epirubicin—urinary bladder cancer	0.000799	0.00134	CcSEcCtD
Apomorphine—Dizziness—Methotrexate—urinary bladder cancer	0.000798	0.00134	CcSEcCtD
Apomorphine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000773	0.0013	CcSEcCtD
Apomorphine—Vomiting—Methotrexate—urinary bladder cancer	0.000767	0.00129	CcSEcCtD
Apomorphine—Headache—Methotrexate—urinary bladder cancer	0.000756	0.00127	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—urinary bladder cancer	0.00075	0.00126	CcSEcCtD
Apomorphine—Dizziness—Epirubicin—urinary bladder cancer	0.000747	0.00126	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—urinary bladder cancer	0.000739	0.00124	CcSEcCtD
Apomorphine—Vomiting—Epirubicin—urinary bladder cancer	0.000718	0.00121	CcSEcCtD
Apomorphine—Nausea—Methotrexate—urinary bladder cancer	0.000717	0.00121	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000715	0.0012	CcSEcCtD
Apomorphine—Headache—Epirubicin—urinary bladder cancer	0.000708	0.00119	CcSEcCtD
Apomorphine—Dizziness—Doxorubicin—urinary bladder cancer	0.000691	0.00116	CcSEcCtD
Apomorphine—Nausea—Epirubicin—urinary bladder cancer	0.000671	0.00113	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—urinary bladder cancer	0.000664	0.00112	CcSEcCtD
Apomorphine—Headache—Doxorubicin—urinary bladder cancer	0.000655	0.0011	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—urinary bladder cancer	0.000621	0.00104	CcSEcCtD
